Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

REPORT DESCRIPTION
Enteric Disease Testing Market is Expected to Reach to USD 3.6 Billion Globally by
2019: Transparency Market Research
Transparency Market Research is Published new Market Report " Enteric Disease Testing
Market (Amebiasis, C.difficile Infection, Campylobacteriosis, Cholera,
Cryptosporidiosis, E.coli Infection, Giardiasis, H.pylori Infection, Norovirus
Infection, Rotavirus Infection, Salmonellosis and Shigellosis) - Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global enteric
disease testing market was valued at USD 3.1 billion in 2012 and is expected to grow at a
CAGR of 2.4% from 2013 to 2019, to reach an estimated value of USD 3.6 billion in 2019.
Enteric diseases are major causes of morbidity and mortality worldwide. Developing socio-
economic countries with poor drainage, sanitation along with overcrowding and low hygiene
awareness account for majority of enteric infection incidences prevailing worldwide. These
diseases usually exhibit mild symptoms but if not treated on time can lead to severe
complications, resulting in death. In order to manage these diseases effectively, their early
detection is essential. Various enteric diseases responsible for diarrhea, stomach pain,
nausea, vomiting, anorexia, weight loss and fever are amebiasis, giardiasis, rotavirus
infection, salmonellosis and shigellosis.
Transparency Market Research
Enteric Disease Testing
Market - Global Industry
Analysis, Size, Share,
Growth, Trends and
Forecast, 2013 – 2019
Multi User License: US $ 75795
Corporate User License: US $ 10795
Buy Now
Request Sample
Published Date: Sept 2013
92 Pages Report

Traditionally, diagnosis of enteric infections relied on culture results of fecal specimen.
Today, the world is witnessing a paradigm shift from culture to EIA (enzyme
immunoassaya) and PCR (polymerase chain reaction) based tests owing to advantages
associated with these newer testing methods. EIA and PCR tests offer enhanced sensitivity
and specificity compared to culture tests and also give quick results. Globally the market for
enteric disease testing is growing at a CAGR of 2.4% under the influence of rising
awareness, demand for point of care testing and increasing application of molecular
diagnostics. Use of molecular diagnostic products has made diagnosis easy and possible,
even those strains which once seemed to be difficult and impossible. North America and
Europe represent the largest regional markets because of rapid demand for molecular based
diagnostics and due to high level of awareness among people about the diseases. C.difficile
infection is one of the major causes of antibiotic related diarrhea in developed regions.
Various epidemiological sources including CDC and American Association for Clinical
Chemistry suggest that C.difficile infection incidence per 100,000 people has increased over
the past few decades in United States. In developing nations, frequent travelling to regions
where enteric diseases are epidemic is also one of the reasons driving the market growth.
Asia-Pacific and Africa have been predicted to grow rapidly during the forecast period. In
developing nations of Asia-pacific, Africa and Latin America, the market is also growing due
to advent of rapid dipstick tests which can be applied by the patient themself. These regions
associated with inadequate healthcare infrastructure do not possess substantial number of
laboratories to perform laboratory based tests. Thus, rapid dipstick test kits being
inexpensive and easy to use are widely accepted in these regions for managing enteric
illness. Continuously improving economy and rising healthcare expenditure in these regions
are also anticipated to drive the market. The market is also growing due to emergence of
new strains; sources from Eurosurveillance suggest that the norovirus infection is increasing
worldwide, including United Kingdom, the Netherlands, France, Japan and Australia due to
emergence of new strain of genotype II.4 (GII.4) that is also known as Sydney strain.
Some of the major companies leading the market for enteric disease testing are DiaSorin,
Cepheid, Bio-Rad, Trinity Biotech, Biomerica, Becton Dickinson, Meridian Bioscience, Alere
and bioMerieux.
The global enteric disease testing market is segmented into the following categories:
Enteric Disease Testing Market, by types of diseases
 Bacterial Enteric Disease Testing
o C.difficile Infection
o Campylobacteriosis
o Cholera

o E.coli Infection
o H.pylori Infection
o Salmonellosis
o Shigellosis
 Viral Enteric Disease Testing
o Rotavirus Infection
o Norovirus Infection
 Parasitic Enteric Disease Testing
o Amebiasis
o Cryptosporidiosis
o Giardiasis
Enteric Disease Testing Market, by Geography
 North America
 Europe
 Asia-Pacific
 Africa
 Latin America
 Rest of the World (RoW)
TABLE OF CONTENTS
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation: Enteric Disease Testing
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research

1.3.1.2 Primary Research
1.4 Assumptions And Intimations
Chapter 2 Executive Summary
2.1 Market Introduction
2.2 Comparison Analysis By Geography: Enteric Disease Testing Market (2012 & 2019)
Browse the full report with complete TOC
at http://www.transparencymarketresearch.com/enteric-disease-testing-
market.html
Chapter 3 Enteric Disease Testing Market Overview
3.1 Enteric Diseases
3.2 Rise of Rapid Testing for Enteric Diseases
3.3 Market Dynamics
3.3.1 Drivers
3.3.1.1 Demand for Rapid Diagnosis
3.3.1.2 Untapped Market in Developing Countries
3.3.1.3 Application of Molecular Diagnostics
3.3.2 Restraints
3.3.2.1 Lack of Awareness
3.3.2.2 Mild and Asymptomatic Diseases
3.3.3 Opportunities
3.3.3.1 Increasing Opportunities in Molecular Diagnostics Based Enteric Disease
Testing
3.3.3.2 Developing Nations will be Highly Lucrative Markets
3.4 Porters Five Forces Analysis for Global Enteric Disease Testing Market

3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat from Substitutes
3.4.4 Threat from New Entrants
3.4.5 Degree of Competitive Rivalry
3.5 Market Attractiveness for Enteric Disease Testing Market, By Geography, 2012
Related & Recently Published Reports by Transparency Market Research
 Industrial Controls and Robotics
Market:http://www.transparencymarketresearch.com/industrial-robotics-
market.html
 Glass Packaging
Market: http://www.transparencymarketresearch.com/glass-
packaging.html
 Latin America Adhesives and Sealants
Market:http://www.transparencymarketresearch.com/latin-america-
adhesives-sealants.html
Chapter 4 Global Enteric Disease Testing Market
4.1 Bacterial Enteric Disease Testing Market
4.1.1 Clostridium Difficile Infection
4.1.1.1 Epidemiology
4.1.1.2 Diagnostic Tests and Market Overview
4.1.2 Campylobacteriosis
4.1.3 Cholera

4.1.4 E.Coli Enteric Diseases
4.1.5 Helicobacter Pylori Enteric Diseases
4.1.6 Salmonellosis
4.1.7 Shigellosis
4.2 Viral Enteric Disease Testing Market
4.2.1 Rotavirus
4.2.2 Norovirus Enteric Disease Testing
4.3 Parasitic Enteric Disease Testing Market
4.3.1 Amebiasis
4.3.2 Cryptosporidiosis

4.3.3 Giardiasis
Chapter 5 Global Enteric Disease Testing Market, By Geography, 2011 - 2019 (USD
Million)
5.1 Introduction
5.1.1 North America
5.1.1.1 North America Enteric Disease Testing Market, By Types of Diseases,
2011 - 2019 (USD Million)
5.1.2 Europe
5.1.2.1 Europe Enteric Disease Testing Market, By Types of Diseases, 2011 -
2019 (USD Million)
5.1.3 Asia-Pacific
5.1.3.1 Asia-Pacific Enteric Disease Testing Market, By Types of Diseases, 2011 -
2019 (USD Million)
5.1.4 Africa
5.1.4.1 Africa Enteric Disease Testing Market, By Types of Diseases, 2011 - 2019
(USD Million)
5.1.5 Latin America
5.1.5.1 Latin America Enteric Disease Testing Market, By Types of Diseases, 2011
- 2019 (USD Million)
5.1.6 Rest Of The World
5.1.6.1 Rest of the World Enteric Disease Testing Market, By Types of Diseases,
2011 - 2019 (USD Million)

Browse the full report with complete TOC
at http://www.transparencymarketresearch.com/enteric-disease-testing-
market.html
Chapter 6 Key Player Analysis for Enteric Disease Testing Market, 2012
Chapter 7 Company Profiles
7.1 Alere, Inc.
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 Becton Dickinson & Company
7.3 Biomerica, Inc.
7.4 Biomerieux

7.5 Bio-Rad
7.6 Cepheid
7.7 Coris Bioconcept
7.8 Diasorin

7.9 Meridian Bioscience, Inc.
7.10 Quest Diagnostics
7.11 Trinity Biotech
About Us:
Transparency Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze

information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY – 12207,
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019

Recomendados

Recomendados

Mais conteúdo relacionado

Último

Último (20)

Destaque

Destaque (20)

Enteric Disease Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019